Evidence map›Paper›PMID 41860470›Full record

ArticleBioscience reports2026

Loss of peroxisomal membrane proteins PEX13 and PEX14 disrupts fatty acid oxidation and drives lipid imbalance.

Navia Vinoy, Gary Huang, Daniel Wallace, V Nathan Subramaniam

Abstract read
In one paragraph

Article in Bioscience reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Navia VinoyHepatogenomics Research Group, Queensland University of Technology (QUT), QLD 4059, Australia.
Gary HuangHepatogenomics Research Group, Queensland University of Technology (QUT), QLD 4059, Australia.ORCID 0000-0002-2411-0576
Daniel WallaceCentre for Genomics and Personalised Health, School of Biomedical Sciences, Queensland University of Technology (QUT), QLD 4059, Australia.ORCID 0000-0002-6019-9424
V Nathan SubramaniamHepatogenomics Research Group, Queensland University of Technology (QUT), QLD 4059, Australia.ORCID 0000-0002-4583-7790

Funding

DHAC | National Health and Medical Research Council (NHMRC) 1118888Queensland University of Technology (QUT) N/A
6 · The paper itself

Abstract

Peroxisomal disorders arise from severe peroxisome dysfunction and are frequently linked to liver pathology. Metabolic dysfunction-associated steatotic liver disease, which affects up to 38% of adults worldwide, has driven extensive efforts to identify genes that contribute to its development. In the present study, we investigated the role of two peroxisomal membrane proteins, PEX13 and PEX14, by performing single and dual small interfering RNA-mediated knockdowns in a liver cell line, HUH-7. Steatosis was induced using free fatty acids, and changes in lipid-metabolism gene expression were assessed by quantitative real-time polymerase chain reaction. Knockdown efficiency reached 90% for both genes, and Oil-Red-O staining confirmed successful induction of steatosis. Both single and combined knockdown of PEX13 and PEX14 altered the expression of genes involved in lipid sensing, fatty acid uptake, synthesis, and oxidation. These findings suggest that peroxisomal dysfunction disrupts hepatic metabolic pathways, promoting increased fatty acid uptake and synthesis. Such alterations may contribute to the liver dysfunction observed in patients with peroxisome biogenesis disorders, highlighting the importance of peroxisomal integrity in maintaining lipid homeostasis.

Indexed as

Fatty AcidsFatty LiverLipid MetabolismMembrane ProteinsPeroxisomesCell Line, TumorGene Knockdown TechniquesHepatocytesHumansLiverOxidation-ReductionRepressor ProteinsFatty AcidsMembrane ProteinsPEX14 protein, humanRepressor Proteinsgene silencinghepatocytesmetabolic dysfunction-associated steatotic liver diseasenon alcoholic fatty liver diseaseperoxisomessmall interfering RNA

Identifiers

PMID41860470
PMCPMC13199795

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.